Smartcat is leveraging AI and a compliance focus to meet the surging demands for enterprise content.
The Story
The company highlights its adherence to regulatory standards while deploying AI solutions.
Why It Matters
Content generation and multilingual translation are massive cost centers for European pharma, CROs, and biotech. This signals that AI tools are finally maturing beyond hype, directly addressing critical compliance and data sovereignty needs for regulated content workflows, not just speed.
What To Do About It
I can help you pilot AI for regulatory content generation or translation, ensuring GDPR and EU AI Act compliance from day one, often leveraging your existing M365 investment.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026